Manufacturing / Pharmaceutical Preparations
Grace Therapeutics, Inc.
GRCE
$2.05
+$0.04 (+2.13%)
Price as of Oct 9, 2026 16:23 UTC
46 M
Market Cap (Micro Cap)
Nov 06
Next Earnings
Technical Signals
as of Oct 7
Bearish
0 of 5
Trend
- Above 20-day average $2.12
- Above 50-day average $2.18
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) Down · 114d ago
Volume
- Below-average volume 0.5x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for GRCE options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
12 buys
0 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Oct 05, 2026 | Opaleye Management Inc. | Buy | 1,694 | $3,490 | -1.0% | |
| Oct 02, 2026 | Opaleye Management Inc. | Buy | 20,000 | $41,368 | -1.4% | |
| Oct 01, 2026 | Opaleye Management Inc. | Buy | 38,796 | $78,962 | +0.2% | |
| Sep 29, 2026 | Opaleye Management Inc. | Buy | 7,849 | $16,404 | -2.4% | |
| Sep 23, 2026 | Opaleye Management Inc. | Buy | 5,318 | $11,168 | -2.9% | |
| Sep 23, 2026 | Opaleye Management Inc. | Buy | 5,318 | $11,168 | -2.9% | |
| Sep 21, 2026 | Opaleye Management Inc. | Buy | 9,771 | $20,519 | -2.9% | |
| Sep 21, 2026 | Opaleye Management Inc. | Buy | 9,771 | $20,519 | -2.9% | |
| Sep 17, 2026 | DAVIS A BRIAN | Grant | 0 | -4.2% | ||
| Sep 17, 2026 | NEUGEBOREN EDWARD | Grant | 12,200 | $0 | -4.2% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 06, 2026 | Q1 2027 | -$0.13 | |||
| Jun 26, 2026 | Q4 2026 | -$0.23 | |||
| Jun 23, 2026 | Q4 2026 | -$0.23 | |||
| Mar 31, 2026 | Q4 2026 | -$0.23 | -$0.06 | +74.4% | Beat |
| Dec 31, 2025 | Q3 2026 | -$0.29 | -$0.14 | +51.0% | Beat |
| Sep 30, 2025 | Q2 2026 | -$0.19 | -$0.06 | +68.2% | Beat |
| Jun 30, 2025 | Q1 2026 | -$0.22 | -$0.21 | +6.4% | Beat |
| Mar 31, 2025 | Q4 2025 | -$0.32 | $0.10 | +131.6% | Beat |
Track GRCE with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for GRCE and your entire portfolio.